Pharmadrug All Set For Exponential Growth in European Cannabis Market

Pharmadrug Inc. (CA:BUZZ – $0.05 & US:LMLLF – $0.02) announced a multi-year supply agreement between its 80% owned German subsidiary Pharmadrug Production GmbH and Canada House Wellness Group Inc. [CSE: CHV]. The agreement is part of the Company’s plan to aggressively pursue the medical and potentially recreational cannabis market in Germany and the rest of Europe. All cannabis will be […]

Read more

Aura Health Signals Turning Point With Name Change To Pharmadrug Inc.

Aura Health (CA:BUZZ – $0.04 & US:LMLLF – $0.02) completed its previously announced name change to Pharmadrug Inc. this week. This name better reflects the Company’s core business and models itself after its 80% owned German subsidiary, Pharmadrug Production GmbH. This is a smart move by the Company as part of a greater initiative to expand the distribution and brand […]

Read more

Aura Health Stock Price Shoots Up Thanks to Important Supply Agreement

Just a few days after our initial Research Report on Aura Health (CA:BUZZ – $0.07 & US:LMLLF – $0.05) was published, the Company surprised the markets with a multi-year supply agreement at very attractive conditions. Aura is building a vertically-integrated medical cannabis company with a focus on the European market. In order to do so, the Company established a beachhead […]

Read more

How Aura Health Is Building Tremendous Value in European Cannabis Market

Aura Health (CA:BUZZ – $0.06 & US:LMLLF – $0.05) is building a leading vertically-integrated medical cannabis company with a focus on the European and Israeli markets. Reasons to own Aura Health stock: 1. A cannabis gateway to Europe: by 2028 the European medical cannabis market is estimated to be $123 billion, making it the largest cannabis market on the planet. […]

Read more

Europe-Focused Cannabis Player Ready for Takeoff

We’re excited about the interview that we conducted with Mr. Daniel Cohen, the Chief Executive Officer of Aura Health Inc. (CA:BUZZ – $0.07 & US:LMLLF – $0.06). The Company is focused on building an international network of vertically-integrated cannabis assets with a clear focus on Europe. Mr. Cohen first discusses Pharmadrug, a German importer and distributor of medical cannabis, of […]

Read more